BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Revenue

BGI Genomics had revenue of 904.49M CNY in the quarter ending September 30, 2026, a decrease of -13.24%. This brings the company's total for the last twelve months to 3.72B, up 0.23% year-over-year. In the year 2025, BGI Genomics had annual revenue of 3.71B, down -4.18%. That makes BGI Genomics the 10,653rd largest company in the world by revenue and 1,765th in China.

• Revenue (ttm): 3.72B
• Revenue Growth: +0.23%
• P/S Ratio: 3.81
• Revenue / Employee: 1.04M
• Employees: 3,580
• Market Cap: 14.38B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Mainland China (Excluding Hong Kong, Macau and Taiwan) 3.13B 84.6%
• Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania 286.43M 7.7%
• Europe and Africa 224.64M 6.1%
• Americas 59.83M 1.6%

Fiscal year ended Dec 31, 2025 See the full BGI Genomics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.71B	-161.54M	-4.18%
Dec 31, 2024	3.87B	-482.72M	-11.10%
Dec 31, 2023	4.35B	-2.70B	-38.33%
Jan 1, 2023	7.05B	287.01M	4.24%
Jan 1, 2022	6.77B	-1.63B	-19.42%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error